UNIVERSITY OF COLORADO - SCHOOL OF MEDICINE CURRICULUM LAURA A. STROM
Office Address: EDUCATION/TRAINING
M.D. The Pennsylvania State University, College of Medicine
2004-present Clinical Science Research Certificate
POST GRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS
Internship, (Psychiatry) Pennsylvania State University, College of Medicine
Internship, (Medicine) University of CO, Health Sciences Center
Resident, (Neurology) University of CO, Health Sciences Center
Post doctoral fellowship (Epilepsy) University of CO, Health Sciences Center
FACULTY APPOINTMENTS
2005-present Assistant Professor of Neurology, University of CO, Health Sciences Center
CURRENT LICENSURE State of Colorado # 40393 MEDICAL BOARD CERTIFICATION American Board of Psychiatry and Neurology, 2007 AWARDS AND HONORS
1992 MEMBERSHIPS IN PROFESSIONAL AND SCIENTIFIC SOCIETIES American Academy of Neurology American Clinical Neurophysiology Society American Epilepsy Society CURRENT COMMITTEES / COMMUNITY SERVICE Physicians Advisory Board – Epilepsy Foundation of Colorado CURRENT RESEARCH SUPPORT
Protocol # 08 -0188 An Open Label Extension Study to Evaluate the Safety, Tolerability and Efficacy of Ganaxolone as an Add-on Therapy in Adult Subjects with Epilepsy Consisting of Uncontrolled Partial-onset Seizures. A multi-centered trial (Principal Investigator) Marinus Pharmaceuticals, Inc. Closing November 2009 Supernus Prosper 301 study: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Three- Arm, Parallel Group Study to Evaluate the Efficacy and Safety of Oxcarbazepine Extended-Release (OXC XR) (1200 and 2400mg/day) as Adjunctive Therapy in Subjects with Refractory Partial Seizures due to Epilepsy on up to Three Concomitant Antiepileptic Medications Supernus Prosper 302 study: Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR) as Adjunctive Therapy in Subjects with Refractory Partial Epilepsy on up to Two Concomitant Antiepileptic Medications Sepracor INC Research 093-045 study: Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs PUBLICATIONS/CHAPTERS
1. Strom, L.A., J.R. Anderson, J.R. Gandler. Journal of Chemical Education 69 (7): 588. The
Synthesis of E-Beta-bromostyrene – an experiment illustrating the use of IR bending modes to distinguish E-isomers and Z-isomers and the concept of kinetic and thermodynamic controlled reactions.
2. Spitz MC, Strom LA, Fisch B. Principles and Practice of Electrophysiological and Video
Monitoring in Epilepsy and Intensive Care. Chap. 12 Diagnostic and Localizing Extracranial EEG Features of Epileptic Seizures. (Bruce Fisch, MD, editor) Demos Medical Publishing.
3. Lauren Frey, Laura A. Strom, Archana Shrestha, Mark Spitz. End of dose emergent
psychopathology in ambulatory epilepsy patients taking stable-dose lamotrigine monotherapy: A case series of six patients. Epub ahead of manuscript Epilepsy & Behavior, May 16, 2009.
Center for Clinical & Cosmetic Research Abstract February Pilot clinical study to evaluate the efficacy of the Transdermal Ionto device to minimize pain and discomfort associated with dermatological cosmetic procedures Mark Nestor, MD, PhD and Alex Cazzaniga Center for Cosmetic Enhancement, Aventura, Florida The Transderm Ionto (Mattioli Engineering, Italy S.p.A.) is a me